🐜
|
Associations of Disease-Modifying Therapies With COVID-19 Severity in Multiple Sclerosis
47 auth.
S. Simpson-Yap,
E. De Brouwer,
T. Kalincik,
N. Rijke,
J. Hillert,
Clare Walton,
G. Edan,
Y. Moreau,
T. Spelman,
L. Geys,
T. Parciak,
Clément Gautrais,
Nikola Lazovski,
A. Pirmani,
Amin Ardeshirdavanai,
...
L. Forsberg,
A. Glaser,
R. McBurney,
H. Schmidt,
A. Bergmann,
S. Braune,
A. Stahmann,
R. Middleton,
A. Salter,
R. Fox,
A. van der Walt,
H. Butzkueven,
R. Alroughani,
S. Ozakbas,
J. Rojas,
I. van der Mei,
N. Nag,
R. Ivanov,
Guilherme Sciascia do Olival,
A. Dias,
M. Magyari,
D. Brum,
M. F. Mendes,
R. Alonso,
R. Nicholas,
J. Bauer,
A. Chertcoff,
Ana Zabalza,
G. Arrambide,
Alexander Fidao,
G. Comi,
L. Peeters
|
7 |
2021 |
7 🐜
|
🐜
|
COVID-19 in people with multiple sclerosis: A global data sharing initiative
48 auth.
L. Peeters,
T. Parciak,
Clare Walton,
L. Geys,
Yves Moreau,
E. De Brouwer,
D. Raimondi,
A. Pirmani,
T. Kalincik,
Gilles Edan,
S. Simpson-Yap,
Luc De Raedt,
Yann Dauxais,
Clément Gautrais,
Paulo Rodrigues,
...
Landon McKenna,
Nikola Lazovski,
Jan Hillert,
L. Forsberg,
T. Spelman,
R. McBurney,
H. Schmidt,
A. Bergmann,
S. Braune,
A. Stahmann,
Rod Middleton,
A. Salter,
Bruce Bebo,
J. Rojas,
A. van der Walt,
H. Butzkueven,
I. van der Mei,
R. Ivanov,
Kerstin Hellwig,
Guilherme Sciascia do Olival,
Jeffrey A. Cohen,
W. van Hecke,
R. Dobson,
M. Magyari,
D. Brum,
R. Alonso,
Richard Nicholas,
J. Bauer,
A. Chertcoff,
J. de Seze,
C. Louapre,
G. Comi,
N. Rijke
|
5 |
2020 |
5 🐜
|
🐬
|
Increased rate of hospitalisation for COVID-19 among rituximab-treated multiple sclerosis patients: A study of the Swedish multiple sclerosis registry
T. Spelman,
L. Forsberg,
K. Mckay,
A. Glaser,
J. Hillert
|
5 |
2021 |
5 🐬
|
🐜
|
Associations of DMT therapies with COVID-19 severity in multiple sclerosis
47 auth.
S. Simpson-Yap,
E. De Brouwer,
T. Kalincik,
N. Rijke,
J. Hillert,
Clare Walton,
G. Edan,
Y. Moreau,
T. Spelman,
L. Geys,
T. Parciak,
Clément Gautrais,
Nikola Lazovski,
A. Pirmani,
A. Ardeshirdavani,
...
L. Forsberg,
A. Glaser,
R. McBurney,
H. Schmidt,
A. Bergmann,
S. Braune,
A. Stahmann,
R. Middleton,
A. Salter,
R. Fox,
A. van der Walt,
H. Butzkueven,
Raed Al-Roughani,
S. Ozakbas,
J. Rojas,
I. van der Mei,
N. Nag,
R. Ivanov,
G. D. do Olival,
A. Dias,
M. Magyari,
Doralina Guimarães Brum,
M. F. Mendes,
R. Alonso,
R. Nicholas,
J. Bauer,
A. Chertcoff,
A. Zabalza,
G. Arrambide,
Alexander Fidao,
G. Comi,
L. Peeters
|
5 |
2021 |
5 🐜
|
🐜
|
Comparative analysis of first-year fingolimod and natalizumab drug discontinuation among Swedish patients with multiple sclerosis
9 auth.
T. Frisell,
L. Forsberg,
N. Nordin,
C. Kiesel,
L. Alfredsson,
J. Askling,
...
J. Hillert,
T. Olsson,
F. Piehl
|
5 |
2016 |
5 🐜
|
🐬
|
Bariatric and metabolic surgery in patients with morbid obesity and multiple sclerosis - a nationwide, matched cohort study.
E. Stenberg,
L. Forsberg,
A. Hedström,
J. Hillert,
E. Näslund
|
3 |
2021 |
3 🐬
|
🦁
|
Proportion and characteristics of secondary progressive multiple sclerosis in five European registries using objective classifiers
29 auth.
L. Forsberg,
T. Spelman,
Pernilla Klyve,
A. Manouchehrinia,
Ryan Ramanujam,
Elena F Mouresan,
J. Drahota,
D. Horáková,
H. Joensen,
Luigi Pontieri,
M. Magyari,
D. Ellenberger,
A. Stahmann,
J. Rodgers,
J. Witts,
...
R. Middleton,
R. Nicholas,
V. Bezlyak,
N. Adlard,
T. Hach,
C. Lines,
S. Vukusic,
M. Soilu-Hänninen,
A. van der Walt,
H. Butzkueven,
P. Iaffaldano,
M. Trojano,
A. Glaser,
J. Hillert
|
2 |
2023 |
2 🦁
|
🐬
|
Increased Rate of Hospitalisation for COVID-19 Amongst Rituximab Treated Multiple Sclerosis Patients: A Study of the Swedish MS Registry
T. Spelman,
L. Forsberg,
K. Mckay,
A. Glaser,
J. Hillert
|
2 |
2021 |
2 🐬
|